# EDGAR Filing Document

**Accession Number:** 0000874716
**File Stem:** 0000874716-23-000027
**Filing Date:** 2023-3
**Character Count:** 2889
**Document Hash:** 396d8ad53ed9557426e9daa552e9ea73
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000874716-23-000027.hdr.sgml**: 20230331

**ACCESSION NUMBER**: 0000874716-23-000027

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 4

**FILED AS OF DATE**: 20230331

**DATE AS OF CHANGE**: 20230331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** IDEXX LABORATORIES INC /DE
- **CENTRAL INDEX KEY:** 0000874716
- **STANDARD INDUSTRIAL CLASSIFICATION:** IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
- **IRS NUMBER:** 010393723
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-19271
- **FILM NUMBER:** 23787380

**BUSINESS ADDRESS:**
- **STREET 1:** ONE IDEXX DRIVE
- **CITY:** WESTBROOK
- **STATE:** ME
- **ZIP:** 04092-2041
- **BUSINESS PHONE:** 2075560300

**MAIL ADDRESS:**
- **STREET 1:** ONE IDEXX DRIVE
- **CITY:** WESTBROOK
- **STATE:** ME
- **ZIP:** 04092-2041

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** IDEXX CORP / DE
- **DATE OF NAME CHANGE:** 19600201

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934 (Amendment No.)

---

| | | | |
|:---|:---|:---|:---|
| 🗹 | Filed by the Registrant | ◻ | Filed by a Party other than the Registrant |
| CHECK THE APPROPRIATE BOX: | CHECK THE APPROPRIATE BOX: | CHECK THE APPROPRIATE BOX: | CHECK THE APPROPRIATE BOX: |
| ◻ | Preliminary Proxy Statement | Preliminary Proxy Statement | Preliminary Proxy Statement |
| ◻ | **Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))** | **Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))** | **Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))** |
| ◻ | Definitive Proxy Statement | Definitive Proxy Statement | Definitive Proxy Statement |
| 🗹 | Definitive Additional Materials | Definitive Additional Materials | Definitive Additional Materials |
| ◻ | Soliciting Material Pursuant to §240.14a-12 | Soliciting Material Pursuant to §240.14a-12 | Soliciting Material Pursuant to §240.14a-12 |

---

![idexx2019image61a.jpg](idexx2019image61a.jpg)

**IDEXX Laboratories, Inc.**

(Name of Registrant as Specified in its Charter)

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

---

| | |
|:---|:---|
| PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY): | PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY): |
| 🗹 | No fee required. |
| ◻ | Fee paid previously with preliminary materials. |
| ◻ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |

---

------

![idexxlaboratoriesinc_nax1a.jpg](idexxlaboratoriesinc_nax1a.jpg)

------

![idexxlaboratoriesinc_na2a.jpg](idexxlaboratoriesinc_na2a.jpg)

<br>